After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read More
CAP ’14, the College of American Pathologists annual meeting, September 7–10, will feature advances in molecular medicine, genetic testing, and laboratory technologies.
Read More
Laboratory testing for hematological disorders ranges from highly automated routine laboratory tests to cutting-edge technologies. This post is a sidebar to our May 2014 feature on Hematology Testing.
Read MoreA new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreThe number of pharma-Dx partnering agreements is growing by leaps and bounds. Here’s a brief summary of some recent agreements announced by CLP and other news services: Adaptive Biotechnologies According to company sources,...
Read More